Defence Therapeutics (XCNQ:DTC) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Dividend Payout Ratio?

Defence Therapeutics's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Defence Therapeutics's Dividend Payout Ratio or its related term are showing as below:

XCNQ:DTC's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-27), the Dividend Yield % of Defence Therapeutics is 0.00%.

Defence Therapeutics's Dividends per Share for the months ended in Dec. 2023 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Defence Therapeutics Dividend Payout Ratio Historical Data

The historical data trend for Defence Therapeutics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Dividend Payout Ratio Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Dividend Payout Ratio

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of Defence Therapeutics's Dividend Payout Ratio

For the Biotechnology subindustry, Defence Therapeutics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Defence Therapeutics's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's Dividend Payout Ratio falls into.

Defence Therapeutics Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Defence Therapeutics's Dividend Payout Ratio for the fiscal year that ended in Jun. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jun. 2022 )	/	EPS without NRI (A: Jun. 2022 )
	=	0	/	-0.199
	=	N/A

Defence Therapeutics's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.191
	=	N/A

Defence Therapeutics (XCNQ:DTC) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Defence Therapeutics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director